Vericel Corporation (NASDAQ:VCEL) Shorted Shares Increased By 15.54%

June 27, 2018 - By Sarah Harris

Vericel Corporation (NASDAQ:VCEL) Corporate Logo

Change of 15.54% for Vericel Corporation (NASDAQ:VCEL)’s shares shorted was reported. FINRA announced in June VCEL’s total 1.51 million shares shorted. The up change of 15.54% from 1.30M shares was reported. Former VCEL’s position will need 2 days to recover. It has 738,700 average volume. Vericel Corporation float short is 5.3%.

The stock decreased 3.14% or $0.325 during the last trading session, hitting $10.025.Vericel Corporation has volume of 416,568 shares. Since June 27, 2017 VCEL has risen 389.29% and is uptrending. VCEL outperformed by 376.72% the S&P 500.

Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, makes, markets, and sells patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions.The company has $425.37 million market cap. It markets three autologous cell therapy products, including Carticel and MACI, which are used for the treatment of cartilage defects in the knee; and Epicel, a permanent skin replacement that is used for the treatment of patients with deep-dermal or full-thickness burns comprising greater than or equal to 30 percent of total body surface area in the United States.Last it reported negative earnings. The firm also develops ixmyelocel-T, which is in Phase IIb clinical trial, a patient-specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy.

Vericel Corporation (NASDAQ:VCEL) Ratings Coverage

In total 4 analysts cover Vericel Corp (NASDAQ:VCEL). “Buy” rating has 4, “Sell” are 0, while 0 are “Hold”. 100% are bullish. 7 are the (NASDAQ:VCEL)’s analyst reports since January 2, 2018 according to StockzIntelligence Inc. On Wednesday, April 4 Leerink Swann initiated Vericel Corporation (NASDAQ:VCEL) with “Buy” rating. On Wednesday, March 28 BTIG Research maintained Vericel Corporation (NASDAQ:VCEL) rating. BTIG Research has “Buy” rating and $1300 target. In Thursday, April 12 report BTIG Research maintained the stock with “Buy” rating. On Wednesday, June 20 the rating was maintained by Leerink Swann with “Buy”. In Tuesday, January 2 report Piper Jaffray maintained it with “Buy” rating and $9.0 target. The stock rating was maintained by BTIG Research with “Buy” on Monday, March 5.

Another two news for Vericel Corporation (NASDAQ:VCEL) were recently published by: on June 25, 2018 with title “Vericel Added to Russell 3000® Index”. The other‘s article was titled “Vericel Corporation Announces Proposed Public Offering of Common Stock” and published on May 30, 2018.

Vericel Corporation (NASDAQ:VCEL) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.